How to make an alveolus Weibel E. R. Eur Respir J 2008; 31: 483-485 | |
To reg or not to reg: that is the question in COPD Baraldo S., Saetta M. Eur Respir J 2008; 31: 486-488 | |
Household chemicals: good housekeeping or occupational hazard? Franklin P. Eur Respir J 2008; 31: 489-491 | |
Possible mechanisms underlying the development of cachexia in COPD Wagner P. D. Eur Respir J 2008; 31: 492-501 | |
Peroxisome proliferator-activated receptors: a therapeutic target in COPD? Remels A. H., Gosker H. R., Schrauwen P., Langen R. C., Schols A. M. Eur Respir J 2008; 31: 502-508 | |
Value of chest radiography in phenotyping chronic obstructive pulmonary disease Miniati M., Monti S., Stolk J., Mirarchi G., Falaschi F., Rabinovich R., Canapini C., Roca J., Rabe K. F. Eur Respir J 2008; 31: 509-515 | |
Neoalveolarisation contributes to compensatory lung growth following pneumonectomy in mice Fehrenbach H., Voswinckel R., Michl V., Mehling T., Fehrenbach A., Seeger W., Nyengaard J. R. Eur Respir J 2008; 31: 515-522 | |
Inhibition of VEGF blocks TGF-β1 production through a PI3K/Akt signalling pathway Lee K. S., Park S. J., Kim S. R., Min K. H., Lee K. Y., Choe Y. H., Hong S. H., Lee Y. R., Kim J. S., Hong S. J., Lee Y. C. Eur Respir J 2008; 31: 523-531 | |
Effects of allergen on airway narrowing dynamics as assessed by lung-slice technique Chew A. D., Hirota J. A., Ellis R., Wattie J., Inman M. D., Janssen L. J. Eur Respir J 2008; 31: 532-538 | |
Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Michils A., Baldassarre S., Van Muylem A. Eur Respir J 2008; 31: 539-546 | |
Household chemicals, persistent wheezing and lung function: effect modification by atopy? Henderson J., Sherriff A., Farrow A., Ayres J. G. Eur Respir J 2008; 31: 547-554 | |
Phenotypic characterisation of T-lymphocytes in COPD: abnormal CD4+CD25+ regulatory T-lymphocyte response to tobacco smoking Barcelo B., Pons J., Ferrer J. M., Sauleda J., Fuster A., Agusti A. G. N. Eur Respir J 2008; 31: 555-562 | |
Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation Brekke P. H., Omland T., Holmedal S. H., Smith P., Soyseth V. Eur Respir J 2008; 31: 563-570 | |
Validation and comparison of reference equations for the 6-min walk distance test Cote C. G., Casanova C., Marin J. M., Lopez M. V., Pinto-Plata V., de Oca M. M., Dordelly L. J., Nekach H., Celli B. R. Eur Respir J 2008; 31: 571-578 | |
Endurance shuttle walking test: responsiveness to salmeterol in COPD Brouillard C., Pepin V., Milot J., Lacasse Y., Maltais F. Eur Respir J 2008; 31: 579-584 | |
Multidisciplinary interobserver agreement in the diagnosis of idiopathic pulmonary fibrosis Thomeer M., Demedts M., Behr J., Buhl R., Costabel U., Flower C. D. R., Verschakelen J., Laurent F., Nicholson A. G., Verbeken E. K., Capron F., Sardina M., Corvasce G., Lankhorst I., the Idiopathic Pulmonary Fibrosis International Group Exploring N-Acetylcysteine I Annual (IFIGENIA) study group Eur Respir J 2008; 31: 585-591 | |
Childhood sarcoidosis: long-term follow-up Milman N., Hoffmann A. L. Eur Respir J 2008; 31: 592-598 | |
Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition Dony E., Lai Y-J., Dumitrascu R., Pullamsetti S. S., Savai R., Ghofrani H. A., Weissmann N., Schudt C., Flockerzi D., Seeger W., Grimminger F., Schermuly R. T. Eur Respir J 2008; 31: 599-610 | |
Impact of statins and angiotensin-converting enzyme inhibitors on mortality of subjects hospitalised with pneumonia Mortensen E. M., Pugh M. J., Copeland L. A., Restrepo M. I., Cornell J. E., Anzueto A., Pugh J. A. Eur Respir J 2008; 31: 611-617 | |
Virological diagnosis in community-acquired pneumonia in immunocompromised patients Camps Serra M., Cervera C., Pumarola T., Moreno A., Perello R., Torres A., Jimenez de Anta M. T., Marcos M. A. Eur Respir J 2008; 31: 618-624 | |
Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review Athanassa Z., Siempos I. I., Falagas M. E. Eur Respir J 2008; 31: 625-632 | |
Phosphodiesterase-4 inhibition attenuates pulmonary inflammation in neonatal lung injury de Visser Y. P., Walther F. J., Laghmani E. H., van Wijngaarden S., Nieuwland K., Wagenaar G. T. M. Eur Respir J 2008; 31: 633-644 | |
Exercise training reduces pulmonary ischaemia-reperfusion-induced inflammatory responses Mussi R. K., Camargo E. A., Ferreira T., De Moraes C., Delbin M. A., Toro I. F. C., Brancher S., Landucci E. C. T., Zanesco A., Antunes E. Eur Respir J 2008; 31: 645-649 | |
Neural respiratory drive during apnoeic events in obstructive sleep apnoea Luo Y. M., Wu H. D., Tang J., Jolley C., Steier J., Moxham J., Zhong N. S., Polkey M. I. Eur Respir J 2008; 31: 650-657 | |
Interstitial lung diseases in infants and children Clement A., Eber E. Eur Respir J 2008; 31: 658-666 | |
Anxiety and depression in end-stage COPD Hill K., Geist R., Goldstein R. S., Lacasse Y. Eur Respir J 2008; 31: 667-677 | |
Mediastinal angiomyolipomas in a male patient affected by tuberous sclerosis Warth A., Herpel E., Schmahl A., Hoffmann H., Herth F. J. F., Schirmacher P., Dienemann H., Schnabel P. A. Eur Respir J 2008; 31: 678-680 | |
Definition of COPD: based on evidence or opinion? Pellegrino R., Brusasco V., Viegi G., Crapo R. O., Burgos F., Casaburi R., Coates A., van der Grinten C. P. M., Gustafsson P., Hankinson J., Jensen R., Johnson D. C., MacIntyre N., McKay R., Miller M. R., Navajas D., Pedersen O. F., Wanger J. Eur Respir J 2008; 31: 681-682 | |
Variation in the tumour necrosis factor-α gene is not associated with susceptibility to Asian COPD Teramoto S., Ishii T., Ishii M., Yamamoto H., Yamaguchi Y., Hibi S., Ouchi Y. Eur Respir J 2008; 31: 682-683 | |
Global condensation: a "climate change" towards better standardisation of exhaled breath condensate measurements Rosias P. P. R., Jobsis Q., van de Kant K., Robroeks C., van Schayck C. P., Zimmermann L. J. I., Dompeling E. Eur Respir J 2008; 31: 684-685 | |
Excessive daytime sleepiness in patients with sleep-disordered breathing BaHammam A. Eur Respir J 2008; 31: 685-686 | |
Pulmonary embolism at home Otero R., Jimenez D. on behalf of the Cooperative Study for the Ambulatory Treatment of Patients with Pulmonary Embolism Research Study Group Eur Respir J 2008; 31: 686-687 | |
From the authors Davies C. W. H. Eur Respir J 2008; 31: 687 | |
Reference values for spirometry of the European Coal and Steel Community: time for change Degens P., Merget R. Eur Respir J 2008; 31: 687-688 | |
From the authors Pellegrino R., Viegi G., Levy P., Brusasco V. Eur Respir J 2008; 31: 688-689 | |
Smoking: leading by example? Thursfield R., Brown S. Eur Respir J 2008; 31: 689-690 | |
"INFLUENZA- AND RESPIRATORY SYNCYTIAL VIRUS-ASSOCIATED MORTALITY AND HOSPITALISATIONS". A.G.S.C. JANSEN, E.A.M. SANDERS, A.W. HOES, A.M. VAN LOON AND E. HAK. EUR RESPIR J 2007; 30: 1158-1166.
Eur Respir J 2008; 31: 691 | |